Previous close | 7.48 |
Open | 7.49 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 7.46 - 7.57 |
52-week range | 6.96 - 14.70 |
Volume | |
Avg. volume | 2,099,203 |
Market cap | 29.616B |
Beta (5Y monthly) | 0.97 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.03 (0.39%) |
Ex-dividend date | 29 Apr 2024 |
1y target est | N/A |
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...
(Bloomberg) -- Bayer AG Chief Executive Officer Bill Anderson said the wave of lawsuits over its Roundup weedkiller is an “existential” threat to the company and farmers, ratcheting up the stakes as it considers a controversial legal maneuver.Most Read from BloombergSingapore Air Changes Seatbelt Rules After Fatal TurbulenceSpaceX Weighs Plan to Sell Shares at $200 Billion ValuationThe Rise and Fall of Simon Sadler's Segantii, One of Asia's Most Successful Hedge FundsChina’s $538 Billion Deposit
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.